Results 191 to 200 of about 15,637,953 (365)
ESC Heart Failure, EarlyView.This state‐of‐the‐art review outlines a practical, evidence‐based framework for early acute heart failure management to address critical gaps in current guidance and improve early treatment outcomes. Key components include early identification of co‐existing conditions, bedside haemodynamic profiling, a structured diagnostic approach incorporating both
Anika S. Naidu +22 more
wiley +1 more source
ESC Heart Failure, EarlyView.Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti +23 more
wiley +1 more source
Controlled vocabularies and tags: An analysis of research methods
, 2011 Margaret E. I. Kipp
openalex +2 more sources
ESC Heart Failure, EarlyView.This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz +5 more
wiley +1 more source
RARGE II: an integrated phenotype database of Arabidopsis mutant traits using a controlled vocabulary. [PDF]
Plant Cell Physiol, 2014 Akiyama K +5 more
europepmc +1 more source
Controlled vocabularies for health & medicine
, 2015 This presentation, given at the 2015 Health Libraries Australia professional Development Day in Brisbane, aims to provide guidance for health & medical librarians in maximising value in regard to use of controlled vocabularies for health & medicine. Included are discussions around the differences between controlled language and natural language/
openaire +2 more sources
ESC Heart Failure, EarlyView.Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra +25 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Background Galectin‐3 (Gal‐3) is a circulating biomarker of fibrosis, with higher levels being associated with an increased risk of progression of heart failure and kidney disease. Patients with type 2 diabetes mellitus (T2DM) are at increased risk of both.
Paul M. Haller +12 more
wiley +1 more source